Dr. Rasika Samarasinghe is a senior postdoctoral research fellow at Deakin University, School of Medicine, Australia. She was awarded her PhD from Deakin University for her studies in thedevelopment of nanotherapeutics for targeted drug delivery for the treatment of cancer and inflammatory diseases. Dr.Samarasinghe presently works with the Translational Cancer Research Group of Deakin University and Barwon Health in Geelong. Her research work involves studying epigenetic regulations in paediatric cancers and its effect on RNA and metabolic mechanisms. She also works with pre-clinical drugs and determines the therapeutic effects on glioma and breast cancer. Shehas given numerous invited lectures in Nanomedicine, neuropharmacology, medical diagnostics and pharmacogenetics to undergraduate and higher degree postgraduate students.She has published several research and review papers in peer-reviewed journals, written and edited book chapters and presented in various international and national scientific conferences. Dr. Samarasinghe is an active member of the Australian Epigenetic Alliance andAmerican Inflammation Research Association. She serves as a consulting editor and reviewer in multiple peer-reviewed scientific journals.
Dr.Rasika Samarasinghe research interests are Paediatric cancers, inflammatory and metabolic disorders, nanomedicine, clinical care, drug discovery and delivery..